Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
12.68
-1.07 (-7.78%)
At close: Jan 17, 2025, 4:00 PM
13.17
+0.49 (3.86%)
After-hours: Jan 17, 2025, 6:23 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.48 billion as of January 17, 2025. Its market cap has increased by 302.17% in one year.
Market Cap
1.48B
Enterprise Value
1.36B
1-Year Change
302.17%
Ranking
Category
Stock Price
$12.68
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.48B, an increase of 89.78%. That is a compound annual growth rate of 13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 1.48B | -8.97% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |